Member log in

Forgotten your password?
Hot Topics: Budget 2013 | Unitary plan

David Darling

Pacific Edge sees $100m revenue from US in five years

Preparing reagents for the Cxbladder test
Pattrick Smellie | Monday March 18, 2013 | 7 comments

Dunedin-based bladder cancer detection test inventor announces the registration of its own diagnostic laboratory in Pennsylvania.

"Well done, Pacific Edge. And well done to those who supported this enterprising Dunedin-based company."

Featured comment

Pacific Edge notice alarms fund managers

Full site access now from $120
David Williams | Monday November 05, 2012

Pacific's Edge's $100m American dream

Preparing reagents for the Cxbladder test
David Williams | WEEKEND REVIEW | 3 comments

The bio-medical stock might be running hot on the potential of one cancer test but don't write the Dunedin company off as a one-trick pony.

Rich Lister Masfen's Pacific Edge surges again

David Williams | Monday October 08, 2012 | 1 comment

The Dunedin-based company halted by NZX Market Supervision last month while it explained its share price rise leaps again.

Pacific Edge bladder cancer test nod bodes well for US sales

Peter Kerr | Monday August 06, 2012 | 4 comments

The validation in the American Journal of Urology may be worth up to $100 million a year in five years for its Cxbladder test, the company says.

"...these guys have actually had their science validated by a very well respected medical journal. I say well done to the team in Dunedin."

Featured comment

Pacific Edge plans US expansion

Robert McCambridge | Wednesday February 01, 2012

The healthcare technology company will set up shop in the US by the end of the year.